Hoth Therapeutics Inc (HOTH) Live Share Price, Invest From India

Hoth Therapeutics Inc Stock Performance

as on October 30, 2025 at 7:38 pm IST

Day's Low
Day's High
$1.4
Day's Price Range
$1.47
$1.42
1.41%
Downside
3.52%
Upside
52 Week's Low
52 Week's High
$0.66
52-Week Price Range
$3.8
$1.42
53.85%
Downside
167.61%
Upside

Hoth Therapeutics Inc share price movements today

Previous Close: $1.40
Open: $1.43
Volume: 153.7K
Day's Low - High: $1.4 - $1.47
52 Week Low - High: $0.66 - $3.8

Hoth Therapeutics Inc Historical Returns

1 Month Return: -13.58 %
3 Month Return: + 3.7 %
1 Year Return: + 55.14 %
3 Year Return: -75.37 %
5 Year Return: -96.65 %

Hoth Therapeutics Inc Stock Fundamentals & Key Indicators

Check Hoth Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$18.4M

EPS (TTM)

-0.59

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-14.1M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-104.87%

Hoth Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Hoth Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Hoth Therapeutics Inc	BUY	$18.4M	-96.65%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$62.4B	291.63%	-505.15	-12.96%
Beone Medicines Ltd	NA	$36.4B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$108.3B	100.24%	30.02	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$69.4B	20.12%	15.7	32.13%

Stock Returns calculator for Hoth Therapeutics Inc Stock including INR - Dollar returns

The Hoth Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Hoth Therapeutics Inc investment value today

Current value as on today

₹1,63,444

Returns

₹63,444

(+63.44%)

Returns from Hoth Therapeutics Inc Stock

₹57,778 (+57.78%)

Dollar Returns*

₹5,667 (+5.67%)

Analyst Recommendation on Hoth Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Hoth Therapeutics Inc. Average target price of $5

Hoth Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Hoth Therapeutics Inc.

What analysts predicted

71.6%UPSIDE

Target Price

Current Price

$1.42

Analyzed by

8 Analysts

Target

$5.00

Hoth Therapeutics Inc target price $5, a slight upside of 71.6% compared to current price of $1.42. According to 8 analysts rating.

Hoth Therapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Hoth Therapeutics Inc Stock has decreased by -53% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 30, 2025 to October 30, 2025

Change:-53% versus previous 30 day period

Hoth Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	-	-	-
Gross Profit	0	0	0	0	-	-	-	-	0	-
Operating Income	-2	-1	-2	-1	-2	-1	-2	-2	-3	-2
EBITDA	-2	-1	-2	-1	-2	-1	-2	-2	-3	-2
Interest Expense	0	-	-	0	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-	-	0	-
Income Before Tax	-2	-1	-2	-1	-2	-1	-2	-2	-3	-2
Income Tax Expense	0	0	0	0	-2	-1	-	-	-	-
Net Income	-2	-1	-2	-1	-2	-1	-2	-2	-3	-2
Net Profit Margin	0.00%	0.00%	0.00%	-2859.13%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Hoth Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	-46	0	-	-
Operating Income	-1	-2	-7	-7	-14	-11	-7	-8
EBITDA	-2	-2	-7	-7	-14	-10	0	-8
Interest Expense	-	-	-	-	0	0	-	-
Depreciation	-	0	0	0	0	-	-	-
Income Before Tax	-2	-2	-7	-7	-14	-11	-7	-8
Income Tax Expense	0	0	0	0	0	0	0	-
Net Income	-2	-2	-7	-7	-14	-11	-7	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Hoth Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-1	-2	-1	-2	-1	-2	-2	-3	-2
Operating Cash Flow	-1	-1	-3	-1	-1	-1	-2	-2	-2
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	-	2	-	-	3	-	1	7	0
Change in Cash	-1	0	-2	-1	2	-1	0	4	-2

Hoth Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-7	-7	-14	-11	-7	-8
Operating Cash Flow	-2	-4	-6	-12	-9	-8	-6
Investing Cash Flow	0	0	-1	0	1	-	-
Financing Cash Flow	1	7	8	18	6	11	4
Change in Cash	0	1	0	5	-2	2	-2

Global Institutional Holdings in Hoth Therapeutics Inc

Funds	Holdings
Geode Capital Management, LLC	0.92%
UBS Group AG	0.32%
Vanguard Group Inc	0.29%
BMO Capital Markets Corp.	0.11%
Foundations Investment Advisors, LLC	0.11%

See all

Insights on Hoth Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, HOTH stock has moved up by 2.9%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 135.5% return, outperforming this stock by 210.9%
NO EFFECT
Against Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 71.1% return, outperforming this stock by 16.0%

About Hoth Therapeutics Inc

hoth therapeutics, inc., a biopharmaceutical company, focuses on developing therapies for dermatological disorders. the company focuses on therapies for patients suffering from indications, including eczema, chronic wounds, psoriasis, asthma, and acne. it intends to use the biolexa platform to develop two topical cream products that treat eczema and reduces post-procedure infections for patients undergoing aesthetic dermatology procedures. the company has license agreements with the george washington university; the university of maryland baltimore; isoprene pharmaceuticals, inc.; the north carolina state university; chelexa biosciences, inc.; and the university of cincinnati. it also has a partnership agreement with zylã¶ therapeutics inc. co-develop a new topical treatment for patients with cutaneous lupus erythematosu, a chronic autoimmune disease that affects the skin and is associated with a significant burden on patient quality of life. hoth therapeutics has research collaboratio

Organisation	Hoth Therapeutics Inc
Headquarters	1177 Avenue of the Americas, New York, NY, United States, 10036
Industry	Pharmaceuticals: Major
CEO	Mr. Robb Knie
E-voting on shares	Click here to vote

Key Management of Hoth Therapeutics Inc

Name	Title
Mr. Robb Knie	Founder, President, CEO & Chairman
Mr. David S. Briones	Chief Financial Officer
Ms. Hayley Springer	Executive Vice President of Operations

FAQs

What is Hoth Therapeutics Inc share price today?

Hoth Therapeutics Inc share price today is $1.42 as on October 30, 2025 at 7:38 pm IST. Hoth Therapeutics Inc share today touched a day high of $1.47 and a low of $1.4.

What is the 52 week high and 52 week low for Hoth Therapeutics Inc share?

Hoth Therapeutics Inc share touched a 52 week high of $3.8 on January 7, 2025 and a 52 week low of $0.66 on April 8, 2025. Hoth Therapeutics Inc stock price today i.e. October 30, 2025 at 7:38 pm IST is trending at $1.42,which is 62.63% down from its 52 week high and 116.66% up from its 52 week low.

What is Hoth Therapeutics Inc's market capitalisation today?

Hoth Therapeutics Inc market capitalisation is $0.00T as on October 30, 2025 at 7:38 pm IST.

How to invest in Hoth Therapeutics Inc Stock (HOTH) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Hoth Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hoth Therapeutics Inc Shares that will get you 1.0563 shares as per Hoth Therapeutics Inc share price of $1.42 per share as on October 30, 2025 at 7:38 pm IST.

What is the minimum amount required to buy Hoth Therapeutics Inc Stock (HOTH) from India?

Indian investors can start investing in Hoth Therapeutics Inc (HOTH) shares with as little as ₹88.686 or $1 (as of October 30, 2025 at 7:38 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Hoth Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on October 30, 2025 at 7:38 pm IST). Based on Hoth Therapeutics Inc share’s latest price of $1.42 as on October 30, 2025 at 7:38 pm IST, you will get 7.0423 shares of Hoth Therapeutics Inc. Learn more about fractional shares .

What are the returns that Hoth Therapeutics Inc has given to Indian investors in the last 5 years?

Hoth Therapeutics Inc stock has given -96.65% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?